ONCE-DAILY TIOTROPIUM RESPIMAT® REDUCES EXACERBATION RISK IN PATIENTS WITH SYMPTOMATIC ASTHMA, INDEPENDENT OF T HELPER 2 PHENOTYPE: Abstract ID – 289


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles